Neurotech International Limited (NTI.AX)
Develops medical devices and cannabis treatments for pediatric neurological disorders like autism.
0.02-0.06%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago-15.8%
The outlook
NTI.AX is trading near its 50- and 200-day moving averages and sits in the lower third of its 52-week range. Analyst coverage appears minimal based on available data. The overall sentiment leans bullish, though the stock remains well below recent highs.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range32% of the way from its 52-week low to high
Market cap
$21.2M
52-wk high
0.03
52-wk low
0.01
50-day avg
0.01
200-day avg
0.01
Trailing P/E
—